News

Article

Sponsored Content

A Streamlined Platform Process to Accelerate Biotherapeutics from Gene to Clinic

Author(s):

Harmonizing technological innovation and a platform approach in biomanufacturing can reduce time and cost barriers to produce stable, high-expressing antibody-based therapeutics

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.